DVR-01

CAS No. 330461-34-2

DVR-01 ( DVR 01; DVR01; 3-(azepan-1-ylsulfonyl)-N-benzyl-4-chlorobenzamide )

Catalog No. M27873 CAS No. 330461-34-2

DVR-01 is an HBV capsid inhibitor and can be used in studies about the treatment of Hepatitis B virus (HBV) infection and related conditions.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 393 Get Quote
10MG 581 Get Quote
25MG 888 Get Quote
50MG 1242 Get Quote
100MG 1674 Get Quote
500MG 3348 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DVR-01
  • Note
    Research use only, not for human use.
  • Brief Description
    DVR-01 is an HBV capsid inhibitor and can be used in studies about the treatment of Hepatitis B virus (HBV) infection and related conditions.
  • Description
    DVR-01 is an HBV capsid inhibitor and can be used in studies about the treatment of Hepatitis B virus (HBV) infection and related conditions.
  • Synonyms
    DVR 01; DVR01; 3-(azepan-1-ylsulfonyl)-N-benzyl-4-chlorobenzamide
  • Pathway
    Microbiology/Virology
  • Target
    HBV
  • Recptor
    Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    330461-34-2
  • Formula Weight
    406.9
  • Molecular Formula
    C20H23ClN2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Clc1ccc(cc1S(=O)(=O)N1CCCCCC1)C(=O)NCc1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Simoni S, et al. Enantioselective Metabolism of Chiral 3-Phenylbutyric Acid, an Intermediate of Linear Alkylbenzene Degradation, by Rhodococcus rhodochrous PB1. Appl Environ Microbiol. 1996 Mar;62(3):749-55.
molnova catalog
related products
  • Besifovir(b)

    Besifovir a parent drug converted by LB80380 further metabolizes to its active form LB80317. LB80380 is potent antiviral agent against hepatitis B virus (HBV).

  • IR415

    IR415 is a novel small molecule inhibitor of HBV virus replication that blocks hepatitis B virus X protein (HBx, Kd=2 nM) mediated RNAi suppression.

  • Inarigivir ammonium

    Inarigivir ammonium is a dinucleotide antiviral compound that significantly reduces HBV DNA in transgenic mice expressing hepatitis B virus. Inarigivir is an agonist of retinoic acid-inducible gene-I (RIG-I) that activates intracellular innate immunity.